GM

Graham McLean

CleanSpace Holdings Limited | Executive Director, Chief Executive Officer
Mr McLean has more than 20 years' business and corporate governance experience and is an experienced senior executive leader with service in the medical technology industry in Australia, Asia and US, most recently with Stryker Corporation ('Stryker') as President Asia Pacific. Whilst at Stryker, Mr McLean led a transformation of Asia Pacific to renew growth in Japan and China and led an accelerated growth strategy for Australia/New Zealand. Prior to his time with Stryker, Mr McLean was Lion Nathan's Finance Director International/Business Development and Director Group Risk Assurance & Audit. Since 2021, Mr McLean has served as an Independent Director and Chairman of the Audit and Risk Committee at both Suicide Prevention Australia and also is an Advisor to Bain & Company. He has also previously served on industry boards in Australia (Medical Technology Association of Australia), Japan (American Medical Devices & Diagnostics Manufacturers Association) and Asia Pacific where he was Vice Chairman of the Asia Pacific Medical Technology Association. Mr McLean has - Delivered a recovery for Stryker's business in Japan; Rebuilt the Stryker China business with an investment and talent plan; Extended market leadership and share gains in Australia/New Zealand; restructured Lion Nathan's international operations to set springboard for further international growth; and Introduced risk management systems to Lion Nathan Board, which enabled strategic and operational decisions in China, wine and non-core businesses. He has completed 3 Executive Leadership Programmes (Harvard Business School).

Companies and Roles

Company
Title
Tenure
Since
CSX
CleanSpace Holdings Limited
  • Executive Director
  • Chief Executive Officer
2yrs, 5mthFeb 2022
UBI
Universal Biosensors, Inc.
  • Non-Executive Director
  • Non-Executive Chairman
2yrs, 4mthMar 2022
FPH
Fisher & Paykel Healthcare Corporation Limited
  • Non-Executive Director
9mthOct 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
UBI
Universal Biosensors, Inc.
27/05/2401,080,116N/AN/A
CSX
CleanSpace Holdings Limited
08/04/240315,608N/AN/A
FPH
Fisher & Paykel Healthcare Corporation Limited
N/AN/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
UBI
Universal Biosensors, Inc.
27/05/24
Buy
275,000$0.110$30,250On-market trade
UBI
Universal Biosensors, Inc.
03/05/24
Issued
180,116$0.150$27,017Rights issue
CSX
CleanSpace Holdings Limited
08/04/24
Buy
18,750$0.320$6,000Conversion of securities
CSX
CleanSpace Holdings Limited
08/04/24
Exercise
18,750$0.320$6,000Conversion of securities
UBI
Universal Biosensors, Inc.
11/12/23
Buy
75,000$0.199$14,901On-market trade